Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2005
Published online before print May 5, 2005, doi: 10.1161/01.RES.0000168327.22888.4d
A more recent version of this article appeared on May 27, 2005
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Data Supplement
Right arrow All Versions of this Article:
96/10/1095    most recent
01.RES.0000168327.22888.4dv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chagnon, F.
Right arrow Articles by Lesur, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chagnon, F.
Right arrow Articles by Lesur, O.
Related Collections
Right arrow Contractile function
Right arrow Animal models of human disease
Right arrow Apoptosis
Right arrow Other Treatment
Right arrow Echocardiography

Submitted on December 15, 2004
Revised on April 18, 2005
Accepted on April 21, 2005

Endotoxin-Induced Myocardial Dysfunction. Effects of Macrophage Migration Inhibitory Factor (MIF) Neutralization

Frederic Chagnon ; Christine N. Metz ; Richard Bucala ; and Olivier Lesur *

From the Groupe de Recherche en Physiopathologie Respiratoire (F.C., O.L.), Centre de Recherche Clinique, Universite de Sherbrooke PQ, Canada; The Institute for Medical Research at North Shore-LIJ (C.N.M.), Manhasset, NY; the Department of Internal Medicine (R.B.), Section of Rhumatology, Yale University School of Medicine, New Haven, Conn; and Unite des Soins Intensifs Medicaux (O.L.), CHU Sherbrooke, PQ, Canada.

* To whom correspondence should be addressed. E-mail: Olivier.Lesur{at}USherbrooke.ca.

The pathophysiology of sepsis-induced myocardial dysfunction still remains controversial. Macrophage migration inhibitory factor (MIF) has recently been identified as a cardiac-derived myocardial depressant factor in septic shock. Putative mechanisms by which MIF affects cardiac function are unknown. In an investigation of possible mechanisms of action, a rat model of endotoxin toxicity was designed using intraperitoneal (I/P) injection of lipopolysaccharides (LPS) with or without coinfusion of neutralizing anti-MIF or isotypic-matched antibodies. Echocardiographic evaluation revealed that MIF neutralization reversed endotoxin-induced myocardial dysfunction at 24 hours after injection. RNase protection assay (RPA) and Western blot established that MIF neutralization prevented LPS-induced mRNA expression and production of heart-derived inflammatory paracrine and autocrine cytokines such as IL-1s and IL-6. Moreover, MIF immunoneutralization increased heart Bcl-2/Bax protein ratio and suppressed endotoxin-induced release of mitochondrial cytochrome-c, as demonstrated by Western blotting. Inhibition of mitochondrial loss of cytochrome-c decreased in heart caspase-3 activity at 6 and 24 hours after injection. MIF neutralization also restored the LPS-induced deficient nuclear translocation of phospho-Akt and consequently the expression of the heart survival nuclear factor GATA-4. The restoration of the translocation/expression of survival factors by MIF inhibition resulted in lowered endotoxin-induced DNA fragmentation at 24 hours, a hallmark of downstream cardiomyocyte apoptosis. Our data indicate that early inactivation of MIF significantly reverses the imbalance of proapoptotic to prosurvival pathways and reduces acute inflammation of the heart thereby improving myocardial dysfunction induced by endotoxin.


Key words: sepsis • myocardial dysfunction • migration inhibitory factor neutralization • lipopolysaccharides




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
X. Li, Y. Li, L. Shan, E Shen, R. Chen, and T. Peng
Over-expression of calpastatin inhibits calpain activation and attenuates myocardial dysfunction during endotoxaemia
Cardiovasc Res, July 1, 2009; 83(1): 72 - 79.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Zernecke, J. Bernhagen, and C. Weber
Macrophage Migration Inhibitory Factor in Cardiovascular Disease
Circulation, March 25, 2008; 117(12): 1594 - 1602.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. A. Amaral, C. T. Fagundes, R. Guabiraba, A. T. Vieira, A. L.S. Souza, R. C. Russo, M. P.B. Soares, M. M. Teixeira, and D. G. Souza
The Role of Macrophage Migration Inhibitory Factor in the Cascade of Events Leading to Reperfusion-Induced Inflammatory Injury and Lethality
Am. J. Pathol., December 1, 2007; 171(6): 1887 - 1893.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Kobayashi, K. Mao, H. Zheng, X. Wang, C. Patterson, T. D. O'Connell, and Q. Liang
Diminished GATA4 Protein Levels Contribute to Hyperglycemia-induced Cardiomyocyte Injury
J. Biol. Chem., July 27, 2007; 282(30): 21945 - 21952.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. A. Taylor, Q. Zhu, B. Irwin, Y. Maghaydah, J. Tsimikas, C. Pilbeam, L. Leng, R. Bucala, and G. A. Kuchel
Null mutation in macrophage migration inhibitory factor prevents muscle cell loss and fibrosis in partial bladder outlet obstruction
Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1343 - F1353.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Carlson, D. L. Maass, D. J. White, J. Tan, and J. W. Horton
Antioxidant vitamin therapy alters sepsis-related apoptotic myocardial activity and inflammatory responses
Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2779 - H2789.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Cuenca, P. Martin-Sanz, A. M. Alvarez-Barrientos, L. Bosca, and N. Goren
Infiltration of Inflammatory Cells Plays an Important Role in Matrix Metalloproteinase Expression and Activation in the Heart during Sepsis
Am. J. Pathol., November 1, 2006; 169(5): 1567 - 1576.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Ha, F. Hua, D. Grant, Y. Xia, J. Ma, X. Gao, J. Kelley, D. L. Williams, J. Kalbfleisch, I. W. Browder, et al.
Glucan phosphate attenuates cardiac dysfunction and inhibits cardiac MIF expression and apoptosis in septic mice
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1910 - H1918.
[Abstract] [Full Text] [PDF]